Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bruno Flamion

Showing results (51-60 of 59) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 59 results.
The Journal of Molecular Diagnostics : JMD|June 17, 2008
Validation of real-time methylation-specific PCR to determine O6-methylguanine-DNA methyltransferase gene promoter methylation in gliomaIlse Vlassenbroeck, Stéphane Califice, Annie-Claire Diserens, et al.
Calcified Tissue International|March 22, 2013
Health technology assessment in osteoporosisMickael Hiligsmann, John A Kanis, Juliet Compston, et al.
Rheumatology (Oxford, England)|January 19, 2011
Updating the 2003 European regulatory requirements for registering disease-modifying drugs to be used in the treatment of rheumatoid arthritisJosef S Smolen, Maarten Boers, Eric C Abadie, et al.
Current Medical Research and Opinion|April 6, 2013
How to define responders in osteoarthritisCyrus Cooper, Jonathan D Adachi, Thomas Bardin, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|August 11, 2005
Recommendations for an update of the current (2001) regulatory requirements for registration of drugs to be used in the treatment of osteoporosis in postmenopausal women and in menJean-Yves Reginster, Eric Abadie, Pierre Delmas, et al.
Aging Clinical and Experimental Research|January 1, 2016
Recommendations for the conduct of clinical trials for drugs to treat or prevent sarcopeniaJean-Yves Reginster, Cyrus Cooper, René Rizzoli, et al.
Current Medical Research and Opinion|December 15, 2010
Recommendations for an update of 2003 European regulatory requirements for registration of drugs to be used in the treatment of RAJosef S Smolen, Maarten Boers, Eric C Abadie, et al.
Nature Reviews. Drug Discovery|March 2, 2010
Challenges with advanced therapy medicinal products and how to meet them, , Christian K Schneider, et al.
Nature Biotechnology|May 12, 2010
Renal biomarker qualification submission: a dialog between the FDA-EMEA and Predictive Safety Testing ConsortiumFrank Dieterle, Frank Sistare, Federico Goodsaid, et al.
Pageof 6

Showing results (51-60 of 59) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 59 results.
The Journal of Molecular Diagnostics : JMD|June 17, 2008
Validation of real-time methylation-specific PCR to determine O6-methylguanine-DNA methyltransferase gene promoter methylation in gliomaIlse Vlassenbroeck, Stéphane Califice, Annie-Claire Diserens, et al.
Calcified Tissue International|March 22, 2013
Health technology assessment in osteoporosisMickael Hiligsmann, John A Kanis, Juliet Compston, et al.
Rheumatology (Oxford, England)|January 19, 2011
Updating the 2003 European regulatory requirements for registering disease-modifying drugs to be used in the treatment of rheumatoid arthritisJosef S Smolen, Maarten Boers, Eric C Abadie, et al.
Current Medical Research and Opinion|April 6, 2013
How to define responders in osteoarthritisCyrus Cooper, Jonathan D Adachi, Thomas Bardin, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|August 11, 2005
Recommendations for an update of the current (2001) regulatory requirements for registration of drugs to be used in the treatment of osteoporosis in postmenopausal women and in menJean-Yves Reginster, Eric Abadie, Pierre Delmas, et al.
Aging Clinical and Experimental Research|January 1, 2016
Recommendations for the conduct of clinical trials for drugs to treat or prevent sarcopeniaJean-Yves Reginster, Cyrus Cooper, René Rizzoli, et al.
Current Medical Research and Opinion|December 15, 2010
Recommendations for an update of 2003 European regulatory requirements for registration of drugs to be used in the treatment of RAJosef S Smolen, Maarten Boers, Eric C Abadie, et al.
Nature Reviews. Drug Discovery|March 2, 2010
Challenges with advanced therapy medicinal products and how to meet them, , Christian K Schneider, et al.
Nature Biotechnology|May 12, 2010
Renal biomarker qualification submission: a dialog between the FDA-EMEA and Predictive Safety Testing ConsortiumFrank Dieterle, Frank Sistare, Federico Goodsaid, et al.
Pageof 6